Targeting exercise interventions to patients with cancer in need: an individual patient data meta-analysis

LM Buffart, MG Sweegers, AM May… - JNCI: Journal of the …, 2018 - academic.oup.com
Background Exercise effects in cancer patients often appear modest, possibly because
interventions rarely target patients most in need. This study investigated the moderator …

A review of the literature on symptom clusters in studies that included oncology patients receiving primary or adjuvant chemotherapy

C Ward Sullivan, H Leutwyler, LB Dunn… - Journal of clinical …, 2018 - Wiley Online Library
Aims and objectives To summarise the current state of knowledge of symptom clusters
research from studies that included, as part of their sample, patients who were receiving …

[HTML][HTML] Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study

MC Janelsins, CE Heckler, LJ Peppone… - Journal of Clinical …, 2018 - ncbi.nlm.nih.gov
Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a
Nationwide Cohort Study - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer

DG Stover, CR Gil Del Alcazar, J Brock, H Guo… - NPJ breast …, 2018 - nature.com
Preclinical data support a role for the IL-6/JAK2/STAT3 signaling pathway in breast cancer.
Ruxolitinib is an orally bioavailable receptor tyrosine inhibitor targeting JAK1 and JAK2. We …

The role of inflammation in the pain, fatigue, and sleep disturbance symptom cluster in advanced cancer

KL Kwekkeboom, L Tostrud, E Costanzo… - Journal of pain and …, 2018 - Elsevier
Context Symptom researchers have proposed a model of inflammatory cytokine activity and
dysregulation in cancer to explain co-occurring symptoms including pain, fatigue, and sleep …

Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial

CE Mosher, E Secinti, R Li, AT Hirsh, J Bricker… - Supportive Care in …, 2018 - Springer
Purpose Breast cancer is the leading cause of cancer mortality in women worldwide. With
medical advances, metastatic breast cancer (MBC) patients often live for years with many …

[HTML][HTML] Informing the tolerability of cancer treatments using patient-reported outcome measures: summary of an FDA and critical path institute workshop

PG Kluetz, B Kanapuru, S Lemery, LL Johnson… - Value in Health, 2018 - Elsevier
Abstract The US Food and Drug Administration and the Critical Path Institute's Patient-
Reported Outcome (PRO) Consortium convened a cosponsored workshop on the use of …

Randomized controlled trial of a brief cognitive‐behavioral strategies intervention for the pain, fatigue, and sleep disturbance symptom cluster in advanced cancer

K Kwekkeboom, Y Zhang, T Campbell… - Psycho …, 2018 - Wiley Online Library
Objective Patients receiving treatment for advanced cancer suffer significant symptom
burden, including co‐occurring pain, fatigue, and sleep disturbance. There is limited …

Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy

ALM Williams, R Shah, M Shayne, AJ Huston… - Journal of …, 2018 - Elsevier
Background Cancer-related cognitive impairment (CRCI) is often related to chemotherapy.
Increased chronic inflammation is believed to play a key role in the development of CRCI …

[HTML][HTML] Symptom severity, anxiety, depression, self-efficacy and quality of life in patients with cancer

S Omran, S Mcmillan - Asian Pacific journal of cancer prevention …, 2018 - ncbi.nlm.nih.gov
Background: Despite advances in cancer disease prevention, diagnosis, and treatment
patients with cancer suffer from a variety of sometimes severe physical and psychological …